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Abstract
The mammalian heart has little capacity to regenerate, and following injury the myocardium is replaced by non-contractile
scar tissue. Consequently, increased wall stress and workload on the remaining myocardium leads to chamber dilation,
dysfunction, and heart failure. Cell-based therapy with an autologous, epigenetically reprogrammed, and cardiac-
committed progenitor cell source could potentially reverse this process by replacing the damaged myocardium with
functional tissue. However, it is unclear whether cardiac progenitor cell-derived cardiomyocytes are capable of attaining
levels of structural and functional maturity comparable to that of terminally-fated cardiomyocytes. Here, we first describe
the derivation of mouse induced pluripotent stem (iPS) cells, which once differentiated allow for the enrichment of Nkx2-
5(+) cardiac progenitors, and the cardiomyocyte-specific expression of the red fluorescent protein. We show that the cardiac
progenitors are multipotent and capable of differentiating into endothelial cells, smooth muscle cells and cardiomyocytes.
Moreover, cardiac progenitor selection corresponds to cKit(+) cell enrichment, while cardiomyocyte cell-lineage
commitment is concomitant with dual expression of either cKit/Flk1 or cKit/Sca-1. We proceed to show that the cardiac
progenitor-derived cardiomyocytes are capable of forming electrically and mechanically coupled large-scale 2D cell cultures
with mature electrophysiological properties. Finally, we examine the cell progenitors’ ability to form electromechanically
coherent macroscopic tissues, using a physiologically relevant 3D culture model and demonstrate that following long-term
culture the cardiomyocytes align, and form robust electromechanical connections throughout the volume of the
biosynthetic tissue construct. We conclude that the iPS cell-derived cardiac progenitors are a robust cell source for tissue
engineering applications and a 3D culture platform for pharmacological screening and drug development studies.
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Introduction
An estimated one million US adults suffer a myocardial
infarction annually, with six million having developed heart
failure [1]. The calculated direct and indirect annual costs of
managing heart disease are estimated at close to 180 billion
dollars, amounting to approximately 9% of total healthcare
expenditure in the US. Despite this significant health and
economic burden, there are currently no effective treatments for
heart failure short of a heart transplant. Drugs such as beta-
blockers, angiotensin-converting enzyme inhibitors, and anti-
arrhythmic medications manage the symptoms rather than tackle
the underlying cause. Regenerative therapeutic approaches
involving the transplantation of cardiogenic cells or engineered
tissues can potentially address the latter by reducing post-infarct
scar tissue formation [2], electromechanically integrating within
the injured myocardium [3], and enhancing cardiac functional
output [4,5].
During mammalian development, the heart is the first organ to
function in the embryo, and distinct populations of cardiac
progenitors give rise to cells that populate the myocardium,
including cardiomyocytes, smooth muscle and endothelial cells [6].
We and others, have previously described a unique population of
embryonic stem (ES) cell-derived cardiac progenitor cells, which
closely resemble their in vivo counterparts during developmental
cardiogenesis both in gene expression and multipotent differenti-
ation capacity [7–11]. In particular the ES cell-derived cardiac
progenitors which are identified and isolated based on the
expression of either T/Flk1 [8], Nkx2-5/Isl1/Flk1 [9], Nkx2-5/
cKit [10], or Nkx2-5 [7], are capable of differentiating into
cardiomyocytes, smooth muscle, and in certain cases endothelial
cells. The physiological relevance of this in vitro differentiation
system was demonstrated in screening assays which allowed the
identification of novel genetic components active during the
earliest stages of in vivo cardiogenesis [7,12,13]. Importantly, ES
cell-derived cardiac progenitors are capable of engrafting in the
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infarcted myocardium, differentiating into the various cell lineages
and effecting a significant functional improvement in cardiac
output [14].
The recent discovery that mouse or human somatic cells can be
epigenetically reprogrammed into induced pluripotent stem (iPS)
cells closely resembling ES cells in their expanded proliferative
capacity and differentiation potential has made it possible to derive
immunocompatible genotype-specific and differentiated cell pop-
ulations [15,16]. Moreover, like their embryonic stem cell analogs,
iPS cells retain the capacity to differentiate towards the cardiac cell
lineage and form therapeutically relevant cells [17–19].
The potential success of a cardiac cell-based therapy depends 1)
on the capacity of the therapeutic cell source to form cardiomy-
ocytes that integrate electromechanically with the host myocardi-
um and provide sufficient vascularization of the nascent tissue, 2)
on the manner of cell delivery allowing for robust initial cell
survival while ensuring long-term engraftment, differentiation, and
functional integration, and 3) on the ability of donor cells to
differentiate towards mature cardiomyocytes that are capable of
reinforcing the failing heart without inducing life-threatening
arrhythmias through electrophysiological incompatibility.
Although a range of cell types are being explored for therapeutic
purposes, many ES cell or iPS cell-based therapeutic approaches
hinge on the implantation of terminally fated cardiomyocytes
[3,20,21]. However, the implantation of cardiomyocytes alone
may not yield optimal results because vascular cells such as
endothelial and smooth muscle cells are necessary for the
formation of new vasculature to nourish the nascent muscle tissue
[22,23]. Thus the use of a multipotent cardiac progenitor cell
population [7,10,14] may present a superior alternative. Although
there is ample evidence that ES and iPS cell-derived cardiomy-
ocytes mature temporally in terms of structural and functional
parameters [24,25], the maturation of cardiomyocytes derived
from cardiac progenitors and their functional performance have
not been examined in detail.
The assembly of an electromechanically functional 3D biosyn-
thetic tissue is expected to provide a significantly improved
therapeutic benefit compared to direct intracoronary or intra-
myocardial cell delivery, including efficient cell retention and
survival at the site of injury, and prevention of ventricular
remodeling by providing localized structural support. Additionally,
a cardiac biosynthetic tissue generated from human cells would
find utility in a microphysiological system for in vitro disease
modeling and drug discovery [26]. Currently, pharmacological
studies are commonly performed on either non-cardiac cell lines
or in two-dimensional (monolayer) cultures of cardiomyocytes
[27,28]. To this end, we and others have recently demonstrated
that cardiomyocyte maturation and function are significantly
improved in three-dimensional biosynthetic tissues [29,30].
Importantly, we discovered that although pure ES-derived
cardiomyocytes alone were not capable of forming functional
biosynthetic tissues and their formation necessitated addition of
fibroblasts, ES-derived cardiac progenitor cells were an excellent
single cell source for the assembly of functional 3D tissue
constructs.
We hypothesize that the generation of highly functional cardiac
biosynthetic tissues using genotype-specific stem cell-derived
cardiac progenitors would be valuable for both therapeutic
interventions and drug development studies. In this study we
aim to identify and characterize iPS cell-derived cardiac progen-
itor cells, determine their differentiation capacity, measure their
functional phenotypic characteristics, and examine their capacity
to form functional cardiac biosynthetic tissues. We derived and
characterized iPS cells from mouse embryonic fibroblasts using a
single polycistronic inducible expression lentiviral vector
(Figure 1A) [15]. To generate cardiac progenitors, we derived
iPS cells stably transfected with two DNA vectors: a Nkx2-5
cardiac-specific enhancer element [7,31] driving expression of
puromycin N-acetyl transferase (PAC), enabling the isolation of
pure populations of cardiac progenitor cells; and a Myh6 promoter
element [32] driving the expression of red fluorescent protein
enabling the tracking of cardiac progenitor-descended cardiomy-
ocytes. We utilized immunofluorescence, gene expression analysis,
intracellular sharp microelectrode recordings and optical mapping
of electrical propagation to assess the properties of differentiating
cardiomyocytes. We also utilized a microfabrication-based ap-
proach [29] to guide the coalescence of the cardiac progenitors
into functional engineered biosynthetic tissue constructs to
determine their functional performance in a physiologically-
relevant 3D setting.
Materials and Methods
Induced Pluripotent Stem Cell Derivation and
Subsequent Transfection
Primary cultures of mouse embryonic fibroblasts (MEFs,
Millipore) were epigenetically reprogrammed into iPS cells using
a previously described polycystronic inducible-expression lentiviral
vector [33] (FU.tet.on.OSKM). Briefly following cell transduction
with the lentiviral vector, cells were cultured in stem cell culture
medium (SC-Mdm) containing DMEM/High Glucose (Life
Technologies), fetal bovine serum (15%, Atlanta Biologicals),
non-essential amino acids (1%, Life Technologies), sodium
pyruvate (1%, Life Technologies), Glutamax-I (1%, Life Technol-
ogies), bMercaptoethanol (55 mM, Life Technologies), gentamicin
(25 mg/ml, Life Technologies), valproic acid (0.5 mM, Sigma),
leukemia inhibitory factor or LIF (103 U/ml, ESGROH, Milli-
pore), and Doxycycline (10 mg/ml, Sigma). Doxycycline was
removed 7 days post induction of transcription factor expression
and individual iPS cell colonies were mechanically picked and
expanded on a feeder layer of mitotically inactivated mouse
embryonic fibroblasts.
Prior to the transfection process, iPS cells underwent two serial
half-hour long pre-plating passages and subsequently cultured on
gelatin-coated polystyrene for 24 hours in order to subtract the
feeder layer cells. The next day the iPS cells were dissociated using
Trypsin/EDTA (0.05%, Life Techologies) into a single cell
suspension and counted. 56106 iPS cells were resuspended in
100 ml of ES cell nucleofection solution (VPH-1001) containing
8 mg of linearized Nkx2-5.Hsp68.PAC plasmid (FspI) and 2 mg of
linearized Myh6.Red2.1.SV40.NeoR plasmid (SspI) and placed in
an electroporation cuvette where the cells were electroporated
using the A-023 nucleofection program (Nucleofector II device,
Lonza Scientific). Transfected iPS cells were plated onto a fresh
MEF feeder layer and neomycin selection (G418 sulfate, 100 mg/
ml, Life Technologies) was initiated 2 days following nucleofection
lasting until we detected clearly visible large undifferentiated iPS
clonal colonies. Subsequently the colonies were mechanically
picked, expanded as individual clones, and screened based on the
described criteria.
Production of Lentiviral Particles and DNA Plasmid
Description
The DNA vector used for the production of lentiviral particles
that allow the inducible expression of the four reprogramming
transcription factors has been previously described (Addgene
plasmid 20321, FU.tet.on.OSKM). To produce viral particles we
used a previously described second generation lentivirus produc-
iPS-Derived Cardiac Progenitors
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tion system utilizing the psPAX2 (packaging proteins, Addgene
plasmid 12660) and pMD2.G (envelope proteins, Addgene
plasmid 12559) vectors (Dr. Didier Trono). We followed a
procedure similar to the one described by Maherali et al [34].
Briefly HEK293T cells were cultured in a standard growth
medium and maintained in T-75 tissue culture flasks pre-coated
with a 0.1% solution of porcine gelatin (Sigma). Cells were allowed
to reach 90% confluency at which point they were transfected in
Opti-MEMH (Life Technologies) with a total of 24 mg of the three
lentiviral vectors (12 mg FU.tet.on.OSKM, 7.7 mg of psPAX2 and
4.3 mg of pMD2.G) using Lipofectamine 2000 (Life Technologies).
The supernatant containing the viral particles was collected at 48
and 96 hours following initial transfection with a final volume of
20 ml. The supernatant was subsequently concentrated to a final
Figure 1. Experimental approach depiction and vectors utilized to derive iPS cells or cardiac progenitor cells. A. Mouse embryonic
fibroblasts were epigenetically reprogrammed into induced pluripotent stem cells following their transduction with an inducible expression
polycystronic lentiviral vector allowing the controlled expression of transcription factors Pou5f1, Sox2, Klf4, and Myc. Subsequently the derived iPS
cells were stably transfected by electroporation with two DNA vectors allowing the genetic selection of cardiac progenitor cells (Nkx2-5 enhancer)
and the detection of cardiomyocytes (Myh6 promoter). iPS cell-derived cardiac progenitors mainly differentiate into cardiomyocytes or smooth
muscle and are used to assemble biosynthetic cardiac tissue constructs within hydrogel-based matrix and a polydimethylsiloxane mold. B. Schematic
depiction of the lentiviral vectors used to derive iPS cells as well as the DNA vectors used to select the cardiac progenitors and identify
cardiomyocytes. C. Brightfield images depicting epigenetic reprogramming of mouse embryonic fibroblasts into iPS cells. Clusters of fibroblasts with
an increased proliferation rate and altered morphology ultimately becoming iPS cell colonies are indicated by white arrows.
doi:10.1371/journal.pone.0065963.g001
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volume of approximately 300 ml using Amicon Ultra-15 centrif-
ugal filter units (Millipore) and stored at 4uC for immediate use or
in aliquots at 280uC for long-term use. To transduce primary
MEFs, the cells were plated at a density of approximately 10,000
cells/cm2 in 6-well plates. The next day 1 ml of SC-Mdm medium
containing 10 ml of each of the two viral concentrates and
sequabrene (8 mg/ml, Sigma) was used to transduce the cells. One
day following viral transduction the medium was exchanged with
fresh SC-Mdm and the cells were subsequently passaged into a
10 cm cell culture plate for epigenetic reprogramming.
For the selection of iPS-derived cardiac progenitors we replaced
the green fluorescent protein in the previously described Nkx2-
5.Hsp68.eGFP DNA vector [7] with the puromycin N-acetyl-
transferase gene (pORF39-PAC, Invivogen). To construct the
Myh6.Red2-1.SV40.NeoR plasmid vector we cloned the Myh6
promoter element in the multi-cloning site of the pDsRed2-1
vector (Clontech).
Maintenance and Differentiation of iPS Cells
Undifferentiated iPS cells were routinely maintained and
passaged on a mitotically inactivated feeder layer of MEFs in
SC-Mdm containing DMEM/High Glucose, 15% fetal bovine
serum, non-essential amino acids, sodium pyruvate, Glutamax-I,
bMercaptoethanol, Gentamicin, and LIF. To initiate differentia-
tion 107 iPS cells were suspended in 30 ml of differentiation
medium (Diff-Mdm, same formula as SC-Mdm without LIF) and
placed into 15 cm tissue culture plates pretreated with poly(2-
hydroxyethyl methacrylate). Addition of ascorbic acid (100 mg/ml)
was initiated on differentiation day 2 and approximately 90% of
the Diff-Mdm was exchanged every 48 hours. For selection of iPS-
derived cardiac progenitors, puromycin (5 mg/ml, Invivogen) was
added to the Diff-Mdm on differentiation day 6 and kept in the
medium for at least three days.
Cell aggregates comprised of iPS-derived cardiac progenitors
were dissociated using a customized enzymatic solution containing
Ca2+/Mg2+-free Hanks Buffered Salt Solution (HBSS, Life
Technologies), Trypsin (2.5 mg/ml, Worthington Biochemicals),
Collagenase Type I (2 mg/ml, Worthington Biochemicals),
DNAse (1 mg/ml, Worthington Biochemicals), and EDTA
(0.02%, Sigma). The aggregates were first washed twice with cold
HBSS solution (4uC) containing only EDTA and then transferred
in cold enzymatic solution in which they were incubated for 5–
10 min. Subsequently the solution containing the aggregates was
transferred in a 37uC water-bath where they were gently shaken
for 10 min. Aggregates were then dissociated into a single cell
suspension by gentle continuous pipetting and filtering through a
70 mm filter.
Confluent monolayer cultures of iPS-derived cardiac progeni-
tors were prepared by plating 1500 cells/mm2 on either AclarH
coverslips (Electron Microscopy Sciences) or tissue culture
polystyrene which was previously coated with a fibronectin
solution (PBS, 25 mg/ml, Sigma). Following plating, iPS-derived
cardiac progenitors were further cultured in Diff-Mdm for an
additional 2 days and then transferred into a serum-free solution
containing an equal ratio of DMEM/F12 and Neurobasal base
medium N2 supplement (16, Life Technologies), B27 supplement
(16, Life Technologies), Glutamax-I, non-essential amino acids,
bMercaptoethanol, BSA (5 mg/ml, Sigma), and Gentamicin.
Cultures of neonatal rat ventricular myocytes were prepared as
previously described [35].
Gene Expression Analysis
Primers were designed using NCBI primer-BLAST. In order to
avoid polymerization of non-specific DNA amplimers, primers
were required to span an exon-exon junction, and the primer pair
was required to be separated by at least one intron on the
corresponding genomic DNA (Table S1).
To perform qualitative RT.PCR analysis and ensure low level
of DNA amplification without signal saturation, following total
RNA isolation (Qiagen, 74104) a one step RT.PCR kit (Qiagen,
21212) was utilized with 23 cycles of amplification for Gapdh and
26–28 cycles (BioRad, MyCycler) for the rest of the genes
analyzed. Quantitative RT.PCR analysis was performed on an
ABI 7300 real-time thermocycler using the QuantiTect SYBR
Green one-step RT.PCR kit (Qiagen, 204243). While performing
the polymerase reactions on the real time thermocyclers we
included the option to get a dissociation curve and also run the
final reaction product on agarose gels in order to ensure that the
only amplimers detected and measured were the expected ones.
The SDS software (ABI, version 1.4) was used to analyze the raw
data and then additional analysis was performed on Microsoft
Excel. Relative quantification was performed using the DDCt
method. For each gene, one-way ANOVA was performed to
determine if there were significant differences in gene expression
throughout the experiment. The day of differentiation was used as
the independent variable, and percentage gene expression
(normalized against Day 14) as the dependent variable. In all
cases, the p-value was found to be very small (,,0.01; not
shown), indicating highly significant changes in gene expression.
Holm-Bonferroni multiple comparison t-tests were then performed
to determine whether individual data points were significantly
different. Holm-corrected p-values ,0.05 were deemed signifi-
cantly different. All statistics were performed using the R software.
Immunofluorescence, Image Capture and Analysis
Prior to initiating the immunostaining procedure cell monolay-
ers, or biosynthetic tissue constructs were briefly washed with PBS
and fixed using paraformaldehyde (2% in PBS, Electron
Microscopy Sciences). Antibodies used included anti-Pou5f1
(Abcam, ab19857), anti-Fut4 (Millipore, MAB4301), anti-Actn2
(Sigma, A7732), anti-Tnnt2 (R&D Biosystems, MAB2444), anti-
Myh6 (Abcam, ab15), anti-Myl2 (Abcam, ab48003), anti-Atp2a2
(Abcam, ab2861), anti-Acta2 (Abcam, ab5694), anti-Tagln
(Abcam, ab10135), anti-Vwf (Abcam, ab6994), anti-Cdh2 (Abcam,
ab12221), and anti-Gja1 (Santa Cruz, sc9059). Secondary
antibodies for detection were purchased from Molecular Probes/
Life Technologies and were all conjugated to the Alexa
fluorochromes. Nuclei were detected using 49, 6-diamidino-2-
phenylindole, dihydrochloride (DAPI, Life Technologies). Fluo-
rescent cell imaging was performed on either a Nikon Eclipse
TE2000-U using a Roper Scientific CoolSnap HQ camera and
the NIS Elements software suite or a Zeiss 510 inverted confocal
microscope. Images analysis was performed using Nikon NIS
Elements, Zeiss AIM LSM Image browser, BioView 3D, and
Adobe Photoshop.
Fluorescence-activated Cell Sorting
Embryoid bodies comprised of differentiating iPS cells were
dissociated using serial gentle enzymatic dissociation (0.05%
Trypsin, HBSS, 4 repeats) before or after addition of puromycin
for selection of the Nkx2-5(+) cardiac progenitor cells. Cells were
incubated with APC or PE/Cy7 conjugated antibodies or isotype
controls and FACS was performed using a BD Biosciences
FACSCanto instrument. Data analysis was performed on Flowing
Software 2. All antibodies used for these experiments were
purchased from Biolegend: APC anti-mouse c-kit (Cat # 105811),
APC rat IgG2b isotype control (Cat # 400611), PE/cy7 anti-
iPS-Derived Cardiac Progenitors
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mouse Sca-1 (Cat # 108113), PE/cy7 rat IgG2a isotype control
(Cat # 400521), and PE/cy7 anti-mouse Flk-1 (Cat # 136413).
Microfabrication and Preparation of PDMS Molds
High-aspect ratio mesoscopic features were patterned onto
silicon wafers using an optimized soft-lithography procedure.
Specifically, ten cm diameter silicon wafers were first cleaned for
15 minutes in a 1:3 mixture of hydrogen peroxide and
concentrated sulfuric acid (Piranha Etch, 80uC). The silicon
wafers were then washed in deionized water, dried with air and
dehydrated on a hotplate at 200uC for 15 minutes. Upon cooling,
a 250 mm thick layer of SU-8 100 photoresist (Microchem) was
spun-coated onto the silicon wafer following the manufacturer’s
protocol. The SU-8 coated wafer was then soft-baked at 95uC for
2 hours, followed by cooling to room temperature. Using this
procedure, 5 additional 250 mm-thick layers were added to a final
thickness of 1500 mm. The final soft-bake cycle was allowed to
proceed at 95uC for additional 12 hours to promote evaporation of
residual solvent from the SU-8 layers.
Photomasks were designed using Postscript and printed onto
mylar transparencies (Advanced Reproductions). Photomasks were
placed in contact with the soft-baked SU-8 layer while the areas
outside the photomask boundaries were covered with aluminum
foil to reduce the total surface area of SU-8 exposed to UV light,
thereby reducing stress produced in the silicon wafer upon the
subsequent hard-baking step. The SU-8 coated silicon wafers were
then exposed to UV light (365 nm) at 12 mW cm22 in a series of
1261-minute exposures followed by 2-minute rest intervals so as to
minimize heating of the photoresist layer. The exposed wafers
were then hard-baked at 40uC for 48 hours to allow complete
cross-linking of the exposed areas, followed by cooling to room
temperature. Finally, the exposed wafers were developed over-
night in polypropylene glycol monomethyl ether acetate (PGMEA)
to dissolve unexposed SU-8, rinsed in isopropyl alcohol and dried
using an air-gun.
SU-8 silicon templates were silanized overnight by placing them
in a vacuum desiccator with approximately 500 ml of (trideca-
fluoro-1,1,2,2-tetrahydrooctyl)-1 trichlorosilane (henceforth re-
ferred to as ‘silane’). Sylgard 184 PDMS (Dow Corning) base
was carefully poured over the SU-8 silicon template and allowed to
cure overnight at 65uC, forming a negative impression of the SU-8
template (PDMS negative). The PDMS negative was detached
from the SU-8 template, silanized and used as a template to create
positive PDMS tissue mold which was used for the culture of tissue
patches. PDMS tissue molds were sonicated in 70% ethanol for 1
hour, dried and subjected to a brief (1 minute) oxygen plasma
ashing step, and kept in 70% ethanol. Nylon frames were pinned
within the tissue molds to facilitate handling of the engineered
tissues. Prior to cell culture, the molds were washed in 0.2%
solution of F-127 pluronic (Invitrogen) in water for 1 hour to
minimize hydrogel adhesion to the PDMS mold. PDMS molds
were then dried with nitrogen and filled with previously prepared
cell/hydrogel solution.
Biosynthetic Tissue Assembly
Engineered cardiac tissues were fabricated using previously
established protocols [29,36]. In brief, iPS-derived cardiac
progenitors were dissociated into a single cell suspension following
two days of puromycin selection. The cells were resuspended in a
mixture of fibrinogen (2 mg/ml, Sigma) containing Matrigel (10%,
BD Biosciences). A small quantity of thrombin was added shortly
before 120 ml of well-mixed cell suspension was pipetted into each
microfabricated tissue mold and allowed to set for 45 minutes in a
37uC/5%CO2 incubator. Each engineered cardiac tissue patch
was then immersed in 2 ml of serum-free medium containing 6-
aminocaproic acid (1 mg/ml, Sigma). Engineered cardiac tissue
patches were maintained for 14 days with media change every two
days.
Electrophysiological Characterization
22 mm circular AclarH coverslips were coated with fibronectin
as previously described [29] and placed in 12-well plates. Single-
cell suspensions of iPS-derived cardiac progenitors were prepared
by enzymatic dissociation and seeded onto the AclarH coverslips at
a density of 0.5 million cells per well in a 2 ml volume of Diff-
Mdm. After 24 hours, medium was changed to serum-free which
was used to maintain the monolayers for up to 16 days, with
medium change every alternate day. Sharp microelectrode
recordings were carried out using an Axon Instruments Multi-
clamp 700B setup with an ROE200 motorized headstage (Sutter
Instruments). Sharp microelectrodes were pulled from borosilicate
glass (Sutter Instruments BF100-50-10) using a Model P-97
brown-flaming micropipette puller (Sutter Instruments). Sharp
electrodes were backfilled with 3 M KCl solution and had a
resistance of 40–60 MV. Pipet capacitance neutralization of 2–
5 mS was applied as appropriate to ensure accurate representation
of upstroke velocity. To perform measurements, cardiac progen-
itor monolayer coverslips were placed in a heated chamber filled
with Tyrodes solution.
Optical mapping of calcium transients was performed using our
previously established protocol [37]. Briefly, engineered cardiac
tissue patches were carefully removed from their molds and
incubated for 30 minutes in the dark with 6 mM Rhod2-AM
(Invitrogen) dissolved on Medium 199 (Gibco). Engineered tissue
patches were then washed twice and incubated for a further 15
minutes in the dark with fresh Medium 199 to allow Rhod2-AM
ester linkages to be completely cleaved. The engineered tissue
patches were then transferred to a temperature-regulated chamber
containing Tyrodes solution mounted on a standard Nikon
fluorescence microscope. An image intensifier and 504-element
photodiode array were positioned at the microscope’s side-port.
Point electrical stimulus was applied to the engineered tissue patch
at 2 Hz using a bipolar platinum wire electrode, and calcium
transients were imaged at 1000 Hz using a 46 objective and an
excitation/emission of 560/600 nm.
Results
Derivation and Characterization of Induced Pluripotent
Stem Cells
To epigenetically reprogram primary cultures of mouse
embryonic fibroblasts (MEFs), we utilized a previously described
[33] lentivirally-delivered polycistronic inducible-expression vector
allowing the controlled over-expression of the murine transcription
factors Pou5f1 (Oct4), Sox2, Klf4, and Myc (Figure 1B). We readily
detected clusters of cells with an increased proliferation rate and a
higher nuclear-to-cytoplasmic size ratio as compared to non-
transduced MEFs within two to three days following induction of
transgene expression through the addition of doxycycline in the
stem cell culture medium (SC-Mdm) containing valproic acid [38]
(Figure 1C). The clusters of proliferating MEFs undergoing
reprogramming grew larger temporally, and within 14 days post
initiation of transcription factor over-expression we detected multi-
layered compact iPS cell colonies with clearly marked borders
closely resembling those of undifferentiated mouse ES cells [7].
Using immunofluorescence we determined that the generated iPS
cells expressed Pou5f1 (Oct4, nuclear localization), Nanog (nuclear
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localization), and Fut4 (SSEA1, cell surface localization)
(Figure 2A, B).
Individual iPS clonal colonies were subsequently mechanically
picked, and expanded on mitotically-inactivated MEF feeder
monolayers in the presence of SC-Mdm and without doxycycline.
Following their initial clonal expansion (2–3 passages) we screened
iPS cell clones using two selection criteria: firstly, we picked clones
displaying a similar phenotype to that observed in cultures of
undifferentiated ES cells; secondly, we selected clones with
colonies that expressed the pluripotent stem cell proteins Pou5f1,
Nanog, and Fut4 as determined by immunofluorescence. Using
quantitative RT-PCR, we measured the relative gene expression
level for Pou5f1, Sox2, Nanog, Rex1, Klf4, and Myc (Figure 2C,
Figure S1). When measuring the gene expression level in iPS cells
we detected a strong and highly significant increase in expression
for Pou5f1, Sox2, Nanog, Gdf3, Utf1, and Rex1 as compared to wild
type MEFs. We did not detect a significant change in the
expression level of Klf4, but observed a significant downregulation
of Myc. Similarly to a previous report [39], we detected significant
differences in the gene expression level of iPS cells as compared to
undifferentiated ES cells (positive control). In particular we
detected a significantly lower gene expression output for Sox2,
Myc, and Rex1, a significantly higher expression for Pou5f1, and
Nanog, and no significant differences for Klf4. Furthermore, by
designing additional primers specific for a region outside the
coding sequence of the reverse transcribed cDNA we were able to
measure the relative expression level for the endogenous
transcripts of Pouf51, Sox2, Klf4, and Myc while at the same time
Figure 2. iPS cell characterization. A–B. Undifferentiated iPS cells express and co-localize transcription factors Pou5f1 and Nanog in their nuclei.
Expression of the surface antigen Fut4 (SSEA-1) is also detected in Pou5f1-expressing iPS cells. Importantly the cells organize in tight compact
colonies similarly to colonies of undifferentiated embryonic stem cells. C. Relative gene expression analysis for Pou5f1, Sox2, Nanog, Rex1, Klf4, and
Myc following three serial expansion passages of the derived iPS cells in the absence of doxycycline. All gene expression levels are normalized against
mouse embryonic fibroblasts using the DDCt method. Error bars represent standard deviation. *, ** and *** indicate p,0.05, 0.01, 0.0001,
respectively, and computed using one-tailed Student’s t-test for comparison of the gene expression levels measured for iPS cells with that measured
for primary MEFs. #indicates significant variance amongst all three groups as determined by one-way ANOVA analysis.
doi:10.1371/journal.pone.0065963.g002
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excluding the exogenous lentiviral transcripts (Figure S2C). Using
the second set of primers we detected a pattern of expression
similar to the one observed when using primers specific for the
coding sequence. In particular, we detected a significant upregula-
tion of endogenous Pou5f1 and Sox2 expression, a significant
downregulation of Myc expression and no change for Klf4
suggesting that the lentivirally-delivered exogenous transgenes
were silenced following withdrawal of doxycycline and epigenetic
reprogramming of MEFs into iPS cells.
Induced Pluripotent Stem Cell-derived Cardiac
Progenitor Cells
To selectively enrich for populations of iPS-derived cardiac
progenitor cells, we utilized a genetic selection approach.
Undifferentiated iPS cells were transfected by electroporation
with two DNA plasmids to allow 1) the expression of puromycin
N-acetyl-transferase (PAC) under the control of a previously
described cardiac specific Nkx2-5 enhancer element [7,31], and 2)
the expression of a red fluorescent protein (RFP) under the control
of the Myh6 promoter element [40] (Figure 1B). Following clonal
selection and expansion of 48 stably transfected neomycin-resistant
iPS clones we performed a screen for the cardiac-specific
expression of the two transgenes. We readily identified iPS clones,
which once differentiated produced spontaneously contracting
RFP(+) cardiomyocytes (Movie S1). Moreover, the individual
stably transfected clones retained expression of iPS markers as
determined by immunofluorescence (Figure S2A, B).
To derive cardiac progenitor cells we used a modified version of
our previously established differentiation protocol [7,29]. In
particular Nkx2-5(+) cardiac progenitors were enriched by adding
puromycin to the culture medium as early as differentiation day 5.
To examine the degree of cardiac progenitor induction and
subsequent cell maturation in cultures of differentiating iPS cells,
we performed temporal gene expression analysis. We screened for
a range of genes expressed at different stages of cardiac
development including pre-cardiac or cardiac transcription
factors, and structural or electrophysiological genes (Figure 3,
Figure S3). Following initiation of iPS differentiation we detected a
rapid decrease in the relative expression level of Pou5f1 followed by
rapid upregulation of Brachyury (T, day 3) and Mesp1 (day 4),
indicative of nascent and pre-cardiac mesoderm induction [8,41].
Initial expression of cardiac transcription factors Nkx2-5, Tbx5,
Mef2c, and Myocd was detected on differentiation day 5 while
initiation of Gata4 expression was detected as early as day 3.
Expression of contractile protein genes Myl2, Myh6, and Tnnt2 was
initiated between days 6 and 8 while their expression levels were
strongly upregulated by day 14. Interestingly, the expression of
Myl7 and Myh7 peaked on differentiation day 8 and subsequently
decreased by day 14. These non-monotonic trends are character-
istic of nascent cardiac differentiation where Myl7 is expressed in
all cardiomyocytes during early development, but becomes
progressively more restricted to the atrial compartments as
differentiation progresses [42]. Myh7, the ‘fetal’ form of cardiac
myosin heavy chain, has been reported to decrease in expression
relative to Myh6 as cardiomyocytes undergo developmental
hypertrophy [43]. Finally, we detected a late but very significant
upregulation in the expression levels of Atp2a2, Cacna1c, Casq2,
Hcn4, Kcnj2, Kcnj3, Pln, Ryr2, and Slc8a1, which are crucial for
establishing a hyperpolarized resting membrane potential, as well
as proper Na+, K+ and Ca2+ handling in the cell. We did not
detect a significant change for Atp2a3, and Kcnd3, although we
detected a decrease in the expression level of Kcnk1.
We have previously described the identification of a multipotent
population of ES cell-derived cardiac progenitors based on the
activation of a cardiac-specific enhancer element of the Nkx2-5
transcription factor [7]. Similar reports have also established that
the Nkx2-5 progenitors additionally express the cKit [10] or Flk1
[9] cell surface markers. We set out to determine whether the iPS
cell-derived Nkx2-5(+) cardiac progenitors also expressed cKit,
Flk1, or Sca-1 which has been previously reported to be expressed
on adult cardiac stem cells [44,45] (Figure 4A). During the early
differentiation process, and prior to the addition of puromycin for
enrichment of Nkx2-5(+) cardiac progenitors, we detected a small
population of single cKit (3.0060.39%) positive cells, while not
detecting a significant population of double positive cells for either
cKit/Flk1 (1.3160.27) or cKit/Sca-1 (1.0560.12). Also, no
RFP(+) cells were detected at the early differentiation timepoint,
which is concomitant with the absence of Myh6 transcripts as
determined by gene expression analysis. Following a short-term
enrichment for the Nkx2-5(+) cardiac progenitors we detected a
significant increase in the population of cells expressing cKit
(18.4760.84%). We also detected RFP expression suggesting
initiation of the cardiomyocyte lineage commitment in a
subpopulation of the enriched cardiac progenitors
(16.0060.93%). We examined whether expression of the cell
surface markers correlated with RFP expression and thus
cardiomyocyte lineage commitment. We first determined that
approximately two thirds (62.0862.27%) of the cKit(+) cells also
expressed RFP. Interestingly, dual expression of either cKit/Flk1
or cKit/Sca-1 tightly correlated with RFP expression
(93.4360.74% and 95.6960.97% respectively), indicating that
co-expression of either Flk1 or Sca-1 with cKit and Nkx2-5(+) is
associated with cardiomyocyte-lineage commitment in the cardiac
progenitor cell population.
Phenotypically when cultured in suspension the derived and
stably transfected iPS cells readily aggregated, forming 3D
embryoid bodies (Figure 4B), which increased in size temporally.
Addition of puromycin in the culture medium starting on
differentiation day 5 or 6 induced short-term large-scale cell death
while a subpopulation of cells remained alive in aggregates.
Expression of RFP was initially detected between days 6 and 7 and
found in aggregates of spontaneously contracting cardiomyocytes
that also expressed Actn2(+) (Figure 4C). We developed a
customized enzymatic blend to dissociate the cell aggregates into
a single cell suspension while ensuring high cell viability and a low
level of post-dissociation cell aggregation. The dissociated single
cells readily attached on fibronectin-coated polystyrene or glass
coverslips forming large-scale monolayers (.10 cm2) of synchro-
nously contracting cells indicative of potential intercellular
electrical coupling, and maintained their structural integrity over
a 4-week period (Figure 4D–E, Movie S2). To examine the multi-
lineage differentiation potential of the iPS-derived cardiac
progenitors, following long-term culture we performed immuno-
fluorescence on cell monolayers. Although the majority of cardiac
progenitors differentiated into cardiomyocytes as determined by
Actn2 staining, we readily detected smooth muscle cells that
stained double positive for Acta2 and Tagln (Figure 4F). In total,
10.9965.18% of the cell population stained positive for the
smooth muscle markers. Finally, we determined that the cardiac
progenitors also differentiated into the endothelial cell lineage. In
particular we detected both large and small colonies of cells
staining positive for Von Willebrand factor (Figure 4G, H) [7].
We also determined that the iPS-derived cardiac progenitors
differentiated into relatively mature cardiomyocytes as demon-
strated by the level of sarcomeric organization of proteins Actn2,
Tnnt2, and Myh6 (Figure 5A–C), and expression of the ventricular
Myl2 protein (Figure 5D). Furthermore, cardiomyocytes in
monolayers exhibited intercellular coupling via the expression
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Figure 3. Gene expression analysis performed on differentiating mouse iPS cells. Temporal gene expression analysis was performed over
the length of 14 days (7 timepoints) on cultures of differentiating mouse iPS cells: Pou5f1 (undifferentiated iPS cells). T, and Mesp1 (precardiac
mesoderm). Nkx2-5, Gata4, Tbx5, Mef2c, and Myocd (early cardiac transcription factors). Nppa, Myl2, Myl7, Myh6, Myh7, and Tnnt2 (mature
cardiomyocyte markers), Atp2a2, Atp2a3, Cacna1c, Casq2, Hc4, Kcnj2, Kcnj3, Kcnk1, Kcnd3, Pln, Ryr2, and Slc8a1 (cardiomyocyte electrophysiology
genes). All gene expression levels were normalized against day 0 undifferentiated iPS (except for Pou5f1) using the DDCt method. Error bars represent
standard deviation. Significant differences in gene expression were determined using one-way ANOVA. Independent variable: differentiation day, and
dependent variable: percentage gene expression. In all cases, the p-value was found to be very small (,,0.01; not shown), indicating highly
significant changes in gene expression. Holm-Bonferroni multiple comparison t-tests were then performed to determine whether an individual data
point on a particular differentiation day was significantly different from that of the previous. Holm-corrected p-values ,0.05 were deemed
significantly different and denoted by an *.
doi:10.1371/journal.pone.0065963.g003
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and spatial organization of Cdh2 (N-Cadherin) and Gja1
(Connexin 43), indicative of the formation of functional electro-
mechanical connections (Figure 5E–F) and also expressed the
cardiac specific ATPase Atp2a2 (Figure 5G). Isolated cultures of
neonatal rat ventricular myocytes were used as a positive control
cell source in order to validate the specificity of antibodies used to
characterize iPS-derived cardiac progenitors and their differenti-
ated progeny (Figure S4).
Electrophysiological Characterization of iPS-derived
Cardiac Progenitors
Sharp electrode recordings in differentiating cardiac progenitor
monolayers were performed either at an intermediate differenti-
ation stage (IDS, Differentiation day 7+7), or at a late differen-
tiation stage (LDS, Differentiation day 7+14) (Figure 6A). At both
IDS and LDS, the cells exhibited synchronous spontaneous
beating at 1–2 Hz. Moreover, at both IDS and LDS, the
differentiating cardiac progenitors exhibited similarly low, stable
resting potentials of 274.1261.07 mV and 275.8661.1 mV
respectively (Figure 6E, p.0.05), as well as similar action potential
amplitudes of 95.462.4 mV and 99.161.4 mV respectively
(Figure 6B, p,0.05). Action potential upstroke velocity at IDS
(149.363.6V/s) was found to be significantly slower than at LDS
(179.569.3V/s; p,0.05) (Figure 6C). APD80 at IDS
(77.263.2 ms) was significantly prolonged as compared to LDS
(60.961.7 ms) (Figure 6D). Taken together, the cardiac progenitor
cell-derived cardiomyocytes electrically matured in monolayer
cultures, consistent with previous reports involving mouse ES and
iPS cell-derived cardiomyocytes [24,46,47].
Engineering and Characterization of Biosynthetic Cardiac
Tissues
To assemble the three-dimensional engineered tissues we first
utilized a recently described [29] soft-lithography process to
fabricate high-aspect ratio mesoscopic features (posts) patterned
onto silicon wafers (Figure 7A–C). Subsequently, the microfabri-
cated molds were recreated with polydimethylsiloxane (PDMS) by
double-casting. Following two days of antibiotic selection (differ-
Figure 4. Cardiac progenitor characterization and multipotential differentiation capacity. A. The percentage of total cells expressing cell-
surface antigens cKit, Flk1, and Sca-1 or the combinations of cKit/Flk1, and cKit/Sca-1 were determined by fluorescence-activated cell sorting before
(gray) and after (black) puromycin addition for enriching Nkx2-5(+) cardiac progenitor cells. No RFP(+) cells were detected before addition of
puromycin. The percentage of the five cell subpopulations also expressing RFP following puromycin addition is noted above the black columns. Error
bars represent standard deviation. *denotes significant change (p,0.05) as determined by t-test statistical analysis. Isotype control antibodies were
used as negative control in order to set the gates for the three cell surface antibodies. B. When cultured in suspension the derived iPS cells readily
aggregated to form three-dimensional embryoid bodies which temporally differentiated into various cell types including spontaneously contracting
cardiomyocytes detected as early as differentiation day 7. C. Following three days of puromycin antibiotic selection aggregates of spontaneously
contracting RFP(+) cardiac progenitors were allowed to attach on gelatin-coated polystyrene. The cells in these aggregates stained positive for
cardiac-specific actinin. D. Enzymatically dissociated and puromycin selected iPS-derived cardiac progenitors formed large-scale monolayers of
spontaneously contracting cells. E. RFP-expressing (Myh6 promoter) and spontaneously contracting cardiomyocytes stained positive for the cardiac-
specific marker Tnnt2. F. Acta2(+)/Tagln(+) smooth muscle cells were detected interspersed within the cultures of Act2(+) cardiomyocytes. G–H. Rare
colonies of endothelial cells with varying size were detected within the cell monolayers as determined by immunostaining for Vwf.
doi:10.1371/journal.pone.0065963.g004
Figure 5. Immunofluorescence characterization of cardiomyocytes differentiated from the cardiac progenitor cells. A–D. The
cardiomyocytes formed well-defined cross-striated sarcomeric structures as determined by the expression and spatial organization of Actn2, Tnnt2,
and Myh6 and also expressed the ventricular specific protein Myl2. E–F. The cells also formed robust intercellular electrical and mechanical
connections as determined by the spatial organization of Cdh2 and Gja1. G. RFP(+) cardiomyocytes stained positive for sodium/potassium ATPase
(Atp2a2).
doi:10.1371/journal.pone.0065963.g005
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entiation days 6–7) iPS-derived cardiac progenitors were enzy-
matically dissociated into single cell suspensions, mixed within a
fibrin/matrigel hydrogel, and applied into the PDMS molds. To
ensure a high level of initial cell viability while avoiding
proliferation of any remaining undifferentiated iPS cells we
cultured the newly formed tissues in high serum medium in the
presence of puromycin for an additional two days and subse-
quently transferred them in serum-free culture conditions.
Within three to four days after gelation, we detected initiation of
hydrogel compaction (Figure 7D) and observed spontaneous
contractile activity. The amplitude of spontaneous contractions
increased correlating with the detection of an increasing number
of RFP(+) cardiomyocytes that became elongated, particularly
along the curved hydrogel edges which formed around the PDMS
posts (Figure 7E–F, Movies S3–S6). Finally within two weeks of
culture in serum free conditions, we detected unidirectional
cardiomyocyte alignment within tissue constructs (Movie S7)
accompanied with macroscopic contractile activity.
To functionally characterize the biosynthetic tissue constructs
we first performed optical mapping of intracellular calcium
transients using our previously established protocols [37]. We
determined that when electrically stimulated by point electrode,
tissue constructs sustained macroscopically uniform action poten-
tial propagation with conduction velocities between 5.0–7.7 cm/s
(n = 3, Figure 7G–H, Movie S8).
Figure 6. Intracellular microelectrode characterization of iPS cell-derived cardiomyocytes. The electrophysiology of RFP-expressing
cardiomyocytes matured temporally in culture. A. Representative cardiomyocyte action potential traces at the intermediate differentiation stage (IDS,
Day 7+7) or late differentiation stage (LDS, Day 7+14). Between IDS and LDS in culture, B. Action potential amplitude was not significantly different
(102.461.9 mV versus 100.962.2 mV). C. Maximum action potential upstroke velocity increased from 149.363.5V/s to 179.569.3V/s. D. Action
potential duration at 80% repolarization decreased from 77.263.2 ms to 60.961.7 ms. E. Maximum diastolic potential was not significantly different
(274.161.1 mV versus 275.961.1 mV).
doi:10.1371/journal.pone.0065963.g006
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Finally we examined the engineered tissue structure with respect
to the spatial distribution of cells and their interconnectivity. We
observed that the maturing cells had significantly compacted the
original hydrogel matrix, allowing for the formation of high-
density intertwined string-like unidirectional fibers with a width
ranging between 150 and 500 mm (Figure 8A). The cardiomyocyte
cytoskeleton was elongated and aligned along the long-axis of the
biosynthetic tissue constructs. Interestingly the cardiomyocytes
remained on the external surface of each individual fiber,
suggesting that inadequate nutrient transport within the entire
volume of the hydrogel was prohibitory for thick tissue formation.
The cytoskeleton of individual cardiomyocytes was comprised of
Figure 7. Engineered tissue patches and optical mapping of action potential propagation. Microfabricated tissue molds cast in PDMS
were used to direct the alignment of iPS cell-derived cardiac progenitor cells in three-dimensional biosynthetic tissue constructs. A. PDMS tissue
mold (sputtered with chrome for greater contrast). B–C. Zygometer surface profiles of the PDMS mold showing 1600 mm tall hexagonal features.
Individual hexagons are 800 mm in length and 200 mm in width. D. An engineered tissue patch removed from its mold, bordered by a nylon mesh
frame to facilitate handling. Elliptical void spaces are a result of tissue compaction away from the hexagonal features. E–F. Live brightfield and RFP
images of the engineered tissue construct within its mold, showing tissue compaction forming elliptical pores around the hexagonal features and live
cardiomyocytes within the tissue patch. G. Isochrone map showing activation times across the tissue patch during propagation (left to right) of an
action potential. Blue pixels represent sites of early activation, and red pixels represent sites of late activation. H. False-color images representing a
calcium transient traversing a tissue patch from left to right as a result of action potential firing. Red pixels represent a high intracellular calcium
concentration, and blue pixels represent a low concentration.
doi:10.1371/journal.pone.0065963.g007
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highly organized mature sarcomeric structures which ran perpen-
dicular to the long axis of the biosynthetic tissues as determined by
staining for either Actn2 or Tnnt2 (Figure 8B–C). To examine
whether the cardiomyocytes were electromechanically coupled we
stained the cells with antibodies against Cdh2 and Gja1, markers
for the mechanical adherens junctions and electrical gap junctions,
respectively (Figure 8D–E). We determined that the cells formed
robust electrical and mechanical connections throughout the
entire tissue, indicating a high degree of structural integrity.
Importantly this level of electrical coupling was consistent along
large-scale regions of the biosynthetic tissue constructs (Figure 8F).
Discussion
Recent studies set out to establish a correlation between the
distinct cell populations present early during development or ES-
cell differentiation in pre-cardiac or cardiac mesoderm and their
lineage-commitment into cardiomyocytes, smooth muscle cells,
and endothelial cells [8–10]. Kattman et al. first reported that a late
expression of Flk1 in conjunction with the pre-cardiac mesoderm
marker Brachyury selectively mark tripotent cardiac progenitor
cells which express Nkx2-5 and are capable of differentiating into
smooth muscle, endothelial cells, and cardiomyocytes [8].Wu et al.
also reported that Nkx2-5(+) cardiac progenitors express cKit and
can differentiate into smooth muscle and cardiomyocytes [10].
Finally, Moretti et al. reported that Isl1/Nkx2-5(+) cardiac progen-
itors express Flk1 and are also tripotent in their differentiation
capacity [9]. Here, we utilize a two plasmid system allowing us to
selectively enrich for iPS-derived Nkx2-5(+) cardiac progenitors
and follow their commitment towards the cardiomyocyte cell
lineage through expression of RFP. We first demonstrate that the
cardiac progenitors are tripotent and capable of differentiating
into the three cell lineages with the myocyte cell lineage being the
most prevalent. We show that Nkx2-5(+) cell selection positively
correlates with cKit enrichment although only approximately two
thirds of these cells commit towards the myocyte cell lineage.
Interestingly, dual expression of cKit with either Flk1 or Sca-1
highly correlates with RFP expression in the Nkx2-5(+) progenitor
population, suggesting that acquisition of either of the two markers
by the Nkx2-5/cKit cells predicts their commitment towards the
myocyte lineage. In the future we plan to examine whether
endothelial cell-lineage commitment within the Nkx2-5(+) cardiac
progenitor cell population can be predicted based on the cell-
surface signature of cKit(+)/Flk1(2) or cKit(2)/Flk1(+).
Successful reprogramming of mouse embryonic fibroblasts into
iPS cells involves incremental levels of characterization, including
mesenchymal-to-epithelial transition and acquisition of an ES cell-
like phenotype, activation of a combination of endogenous genes
associated with pluripotency, e.g. Pou5f1, Sox2, and Nanog,
expression of the appropriate cell-surface markers, e.g. Ssea1,
multipotent differentiation capacity into cell types representing the
three germ layers, capacity to form in vivo teratomas, and
ultimately viable animal production through tetraploid comple-
mentation [16,48]. Although here we perform a detailed
characterization of the pluripotent phenotype of the iPS cells
derived for the purpose of this study, one limitation is that we have
not assayed their ability to form teratomas or transgenic animals as
we are particularly interested in their ability to differentiate into
the cardiovascular cell lineages, which we clearly demonstrate.
Cardiac progenitor cells have been previously isolated from
differentiating ES cells using various strategies including specific
cell-surface marker expression, e.g. Flk-1/KDR [8,49], or through
the activation of particular promoter or enhancer elements, e.g.
Mesp1 [50] and Isl-1 [9,51]. These progenitors represent a
dynamic state during ES cell differentiation, and for murine cells
are typically isolated after differentiation day 5 when transcripts
coding for early cardiac transcription factors are first detected
[10,29,49,51].
During embryonic development or pluripotent stem cell
differentiation, as the cardiac progenitors become committed
and differentiate towards the myocyte cell lineage, the resulting
cells are relatively immature and express significantly lower levels
of cardiac-specific genes such as Myh6, Myl2 and Slc8a1. In
contrast, ES cell-derived cardiomyocytes isolated based on the
activation of either the Myh6 [32], Myl2 [52] or Slc8a1 [53]
promoter element have been shown to be more mature. In
particular these cardiomyocytes express high levels of promoter-
associated genes and show characteristic electrophysiological and
structural features, such as hyperpolarized and stable resting
membrane potentials, fast maximum upstroke velocity during
action potential depolarization, and well-formed myosin heavy
chain, actinin and troponin sarcomeres.
The capacity of the relatively immature cardiac progenitors to
reach a fully functional and mature cardiomyocyte phenotype
following their enrichment and in the absence of a paracrine
cardio-inducing niche has come into question. Kim et al. observed
that the presence of non-cardiomyocytes in differentiating
embryoid bodies influenced the ability of nascent human ES
cell-derived cardiomyocytes to reach full electrophysiological
maturity [25]. In particular cardiomyocytes isolated from their
supporting non-cardiomyocytes at an early stage of differentiation
maintained a more depolarized resting membrane potential and a
slower action potential upstroke velocity, whereas cardiomyocytes
allowed to differentiate in the presence of supporting non-
cardiomyocytes showed a more hyperpolarized resting membrane
potential and a faster upstroke velocity. Similarly, Arai et al.
observed that signaling between visceral endodermal cells and
nascent cardiomyocytes was essential for functional cardiac
differentiation [54]. In the absence of such signaling cues, even
though cardiac progenitors upregulated expression of cardiac
markers such as Myh6, they failed to assume a spontaneously
contracting phenotype. The findings of these studies suggest that
ES cell-derived myocyte-lineage committed cardiac progenitors
may require additional paracrine signaling to reach a fully mature
cardiomyocyte phenotype.
It has been hypothesized that ES cell- or iPS cell-derived
cardiac progenitor cells are an ideal cell source for cell-based
therapies because their multipotent phenotype would allow them
to generate new functional cardiomyocytes and establish the
necessary vasculature. If, however, early isolation of these cells
would negatively impact their potential to form fully mature and
functional cardiomyocytes then their utilization for cell-based
therapies would be compromised.
Here we address this question by demonstrating that Nkx2-5(+)
cardiac progenitor cell-derived cardiomyocytes have robust
expression of structural markers which are characteristic of highly
differentiated cardiomyocytes i.e. highly organized Actn2, Tnnt2
and Myh6 cross-striated sarcomeres. They also express high levels
of Kcnj2 and Kcnj3, which allow a more hyperpolarized resting
membrane potential characteristic of mature cardiomyocytes [55].
This was corroborated by our intracellular sharp electrode
experiments where we measured hyperpolarized, stable resting
membrane potentials between274 mV and276 mV (Fig. 5D), in
good agreement with resting potential of terminally differentiated
mouse cardiomyocytes [56,57]. Furthermore, over the time course
of cardiac progenitor cell differentiation, we measured a significant
increase in the maximum upstroke velocity without significant
changes in resting membrane potential, suggestive of an increase
iPS-Derived Cardiac Progenitors
PLOS ONE | www.plosone.org 13 June 2013 | Volume 8 | Issue 6 | e65963
in fast sodium current density (Fig. 5B), a hallmark of functional
cardiac differentiation. The observed shortening of APD80 over
time is likely attributed to an increase in Ito, the main repolarizing
current in murine cardiomyocytes. Notably, these mature electro-
physiological properties are consistent with those measured in
terminally differentiated ES cell-derived cardiomyocytes [24] and
Myl2-selected cardiomyocytes [52]. Specifically, Maltsev et al. [24]
observed stable resting potentials of 27465.1 mV in late-stage,
terminally differentiated ES cell-derived cardiomyocytes, with an
average upstroke velocity of 232662 V/s and an average action
potential duration ranging from 124–148 ms. Muller et al. [52]
observed stable resting potentials of 268.662.8 mV and an
average action potential duration of 118.3615.2 ms in ventricu-
lar-like ES cell-derived cardiomyocytes selected using the Myl2
Figure 8. Confocal microscopy of three-dimensional engineered biosynthetic tissue constructs containing iPS cell-derived
differentiated cardiac progenitor cells. Representative images of the immunostained cells within the tissue constructs. This series of images was
taken from an area located between the large and small pores within the construct. A. Cells within the biosynthetic tissue constructs significantly
compacted the original hydrogel matrix, allowing for the formation of high-density intertwined string-like fibers. The cardiomyocyte cytoskeleton was
elongated and aligned along the long-axis of the biosynthetic tissue constructs. B–C. The cytoskeletal sarcomeric arrangement was highly organized
and placed perpendicular to the long axis of the biosynthetic tissues. D–F. The cardiomyocytes formed robust electromechanical connections (gap
and adherens junctions) as determined by the level of expression and spatial organization of Gja1 and Cdh2 over long distances. These connections
were often detected perpendicular to the long-axis of the tissue constructs.
doi:10.1371/journal.pone.0065963.g008
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promoter. Taken together, these data demonstrate that iPS cell-
derived myocyte lineage-committed cardiac progenitor cells are
capable of further differentiating into fully mature and functional
cardiomyocytes.
We have previously demonstrated that mouse ES-cell derived
cardiomyocytes alone did not form functional cardiac biosynthetic
tissue constructs and required additional input of cardiac
fibroblasts; whereas a single cell source of ES-derived cardiac
progenitors was sufficient to allow formation of constructs with
advanced electromechanical properties [29]. Thus, for the purpose
of this study we set out to determine whether mouse iPS cell-
derived cardiac progenitors could be utilized to form functional
tissue-like structures in a physiologically-relevant 3D configura-
tion. We chose to utilize extracellular matrix materials that
resemble granulation tissue (a rich mixture of fibrinogen,
fibronectin, and collagen) [58,59] that is formed from blood
plasma components and fibroblast-secreted biomolecules. As early
as 12–24 hours after myocardial infarction, early fibrin-rich
granulation tissue begins to invade the infarct site, and forms a
loose collection of pre-scar tissue for up to 2 weeks post-infarction
[59,60]. Granulation tissue is richly vascularized in the infarct
border zone and has been shown to be a suitable environment for
cell implantation therapies [60,61].
We determined that iPS-derived cardiac progenitors in the 3D
environment were able to differentiate into mature, striated
cardiomyocytes with abundant electromechanical connections
including adherens (Cdh2) and gap junctions (Gja1). We observed
synchronous macroscopic contractions and uninterrupted action
potential propagation throughout the construct, thus demonstrat-
ing that the differentiated cardiomyocytes had formed a well-
integrated, functional tissue. We note that the circumferential
pattern of gap junction expression around each cardiomyocyte
and the relatively low action potential conduction velocity in these
relatively pure cardiomyocyte tissues are characteristic of fetal-
stage, immature myocardium [62], an observation consistent with
our previous studies [29]. Furthermore, similar to previous cardiac
tissue engineering studies, we observed that the cardiomyocytes
formed a functional syncytium only in a relatively thin outer shell
in the engineered tissues, suggesting that the survival and
integration of these cells upon implantation will strongly depend
on access to oxygen and nutrients. Overall, our findings suggest
that the biosynthetic tissue constructs comprised of iPS-derived
cardiac progenitors and composed of granulation-like tissue are
appropriate for contributing to the formation of nascent vascular-
ized myocardial tissue.
In conclusion, here we demonstrate that 1) mouse iPS-derived
Nkx2-5(+) cardiac progenitors are multipotent and capable of
differentiating into cardiomyocytes, smooth muscle, and endothe-
lial cells. Moreover, progenitor cell selection enriches for a cKit(+)
cell population and dual expression of either cKit/Flk1 or cKit/
Sca-1 correlates with myocyte lineage commitment; 2) cardiac
progenitor-descendent cardiomyocytes can reach an advanced
stage of structural and functional maturity in vitro, and 3) when
incorporated in a tissue engineered construct the cardiac
progenitors are able to form well-integrated, functional tissues in
a physiologically-relevant 3D environment. This strongly suggests
that iPS cell-derived cardiac progenitors represent an excellent
source for cell and tissue engineering therapies for heart disease as
well as 3D culture platform for pharmacological screenings and
drug development studies.
Supporting Information
Figure S1 Qualitative gene expression analysis
(RT.PCR) for genes of pluripotency performed on
populations on embryonic stem cells (ES D3, positive
control), mouse embryonic fibroblasts (MEF, negative
control), and induced pluripotent stem cells. Primers
designed specific for a region within the coding sequence are
marked as ‘‘Ex/End’’ whereas primers designed specific for a
region within the transcript but outside the coding region are
marked as ‘‘End’’.
(TIF)
Figure S2 A. Following plasmid DNA delivery by electropora-
tion and antibiotic selection (neomycin), stably transfected iPS cells
kept their morphological phenotype and continued to express
pluripotency markers (Pou5f1, Fut4, and Nanog). B. Primers for
gene expression analysis were designed specific for a region within
the transcripted mRNA molecules of the Pou5f1, Sox2, Klf4, or Myc
genes but outside the coding sequence in order to exclude
expression from the lentivirally delivered transgenes. All gene
expression levels were normalized against mouse embryonic
fibroblasts using the DDCt method. *, ** and ***indicate
p,0.05, 0.01, 0.0001 computed using one-tailed Student’s t-test.
(TIF)
Figure S3 Temporal qualitative gene expression analy-
sis (RT.PCR) for pluripotency genes (Pou5f1, Sox2,
Nanog), precardiac mesoderm genes (T, Mesp1), early
cardiac transcription factors (Nkx2-5, Gata4, Tbx5,
Mef2c, Myocd), and cardiomyocyte genes (Nppa, Myl2,
Myl7, Myh6, Myh7, Tnnt2).
(TIF)
Figure S4 Monolayer cultures of neonatal rat ventricu-
lar myocytes were utilized as positive control to test the
specificity and spatial organization of cardiomyocyte or
smooth muscle proteins: Actn2, Tnnt2, Myh6, Myl2,
Gja1, and Acta2.
(TIF)
Table S1 Primers used for quantitative or qualitative
gene expression analysis.
(XLSX)
Movie S1 Cardiomyocytes within cultures of differenti-
ating mouse iPS cells express the red fluorescent
proteins and initiate spontaneous contraction within 7
days following initiation of differentiation.
(MP4)
Movie S2 Following puromycin selection (2 days) and
enzymatic dissociation single cell suspensions of iPS-
derived cardiac progenitors form compact monolayers
and spontaneous contract.
(MP4)
Movie S3 Cells suspended in the hydrogel matrix within
the PDMS molds initiate contractions.
(MP4)
Movie S4 Cells suspended in the hydrogel matrix within
the PDMS molds initiate contractions.
(MP4)
Movie S5 Cells suspended in the hydrogel matrix within
the PDMS molds initiate contractions.
(MP4)
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Movie S6 Cells suspended in the hydrogel matrix within
the PDMS molds initiate contractions.
(MP4)
Movie S7 Long-term culture of iPS-derived cardiac
progenitors in the biosynthetic tissue constructs form
mature cardiomyocytes, and compact the hydrogel
matrix.
(MP4)
Movie S8 Calcium transient traversing a tissue patch
from left to right as a result of action potential firing.
Red pixels represent a high intracellular calcium concentration,
and blue pixels represent a low concentration.
(MP4)
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